Empowering patients, physicians, drug manufacturers & consumers to make the best drug safety decisions



The World Drug Safety Congress Europe will bring together drug safety, pharmacovigilance, data analytics, epidemiology, and other key players in the biopharma sector. Explore the use of big data and AI in pharmacovigilance, examine benefit-risk management strategies and patient-centric approaches and discuss how you can tackle the challenges of social media and drug safety legislation globally at the World Drug Safety Congress.

The congress is set to bridge the gap between international regulatory bodies, industry professionals and academic representatives and will address how to drive pharmacovigilance operations forward.


Content Tracks 

AI + Automation
Natural Language Processing
Case intake
Cost effective AI implementation
Regulatory implications
Risk Management
GVP Practices
Benefit risk
Local minimisation activities
Signal Detection & Management
Signal evaluation
Detecting medical risks
Surveillance systems
Equitable access
Quality Assurance
Inspection readiness
Regulatory guidance
Automation innovations
Data analytics
ICSR processes
Case Processing
Safety databases
Process automation
Effective collaboration
Local reporting requirements
Medical Devices
Digital health tools
Combination products
Drug delivery systems
Post marketing surveillance
Patient Centricity
Patient support programmes
Consumer centric approaches
Affiliate transformation
PV Outsourcing
System efficiency
Early access programmes


Get Involved At World Drug Safety Congress

Conference Production

George Mullens  
+44 20 8164 3940 


Sponsorship & Exhibition Sales

Rohit Dhap   
+44 20 8164 3001


Marketing Opportunities

Karen Duncan